Opin vísindi

Oral nutrition supplements and between-meal snacks for nutrition therapy in patients with COPD identified as at nutritional risk: a randomised feasibility trial

Show simple item record

dc.contributor Háskóli Íslands
dc.contributor University of Iceland
dc.contributor.author Ingadottir, Arora Ros
dc.contributor.author Beck, Anne Marie
dc.contributor.author Baldwin, Christine
dc.contributor.author Weekes, Christine Elizabeth
dc.contributor.author Geirsdottir, Olof
dc.contributor.author Ramel, Alfons
dc.contributor.author Gislason, Thorarinn
dc.contributor.author Gunnarsdottir, Ingibjorg
dc.date.accessioned 2020-08-06T13:40:02Z
dc.date.available 2020-08-06T13:40:02Z
dc.date.issued 2019-01
dc.identifier.citation Ingadottir AR, Beck AM, Baldwin C, et al. Oral nutrition supplements and between-meal snacks for nutrition therapy in patients with COPD identified as at nutritional risk: a randomised feasibility trial. BMJ Open Resp Res 2019;6:e000349. doi:10.1136/ bmjresp-2018-000349
dc.identifier.issn 2052-4439
dc.identifier.uri https://hdl.handle.net/20.500.11815/1927
dc.description Publisher's version (útgefin grein)
dc.description.abstract Introduction Intervention studies have mainly used oral nutritional supplements (ONS) for the management of patients with chronic obstructive pulmonary disease (COPD) identified as at nutritional risk. In this 12-month randomised feasibility trial, we assessed the (1) feasibility of the recruitment, retention and provision of two interventions: ONS and between-meal snacks (snacks) and (2) the potential impact of the provision of snacks and ONS on body weight and quality of life in patients with COPD. Methods Hospitalised patients with COPD, at nutritional risk, were randomised to ONS (n=19) or snacks (n=15) providing 600 kcal and 22 g protein a day in addition to regular daily diet. The intervention started in hospital and was continued for 12 months after discharge from the hospital. Results Study recruitment rate was n=34 (45%) and retention rate at 12 months was similar for both groups: n=13 (68%) in the ONS group and n=10 (67%) in the Snacks group. Both groups gained weight from baseline to 12 months (2.3±4.6 kg (p=0.060) in the ONS group and 4.4±6.4 kg (p=0.030) in the Snacks group). The St George’s Respiratory Questionnaire total score improved from baseline to 12 months in both groups (score 3.9±11.0 (p=0.176) in the ONS group and score 8.9±14.1 (p=0.041) in the Snacks group). Discussion In patients with COPD who are at nutritional risk snacks are at least as feasible and effective as ONS, however, adequately powered trials that take account of the difficulties in recruiting this patient group are required to confirm this effect. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0
dc.description.sponsorship This paper presents independent research that was supported by the Icelandic Research Fund of the Icelandic Centre for Research (141216-051), the Eimskip University Fund and the Landspitali University Hospital Research Fund. Oral nutritional supplements were partly funded by Nutricia (Icepharma) and between meals by MS Iceland Dairies (Mjólkursamsalan).
dc.format.extent e000349
dc.language.iso en
dc.publisher BMJ
dc.relation.ispartofseries BMJ Open Respiratory Research;6(1)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Mataræði
dc.subject Hollusta matar
dc.subject Lungnasjúkdómar
dc.title Oral nutrition supplements and between-meal snacks for nutrition therapy in patients with COPD identified as at nutritional risk: a randomised feasibility trial
dc.type info:eu-repo/semantics/article
dcterms.license This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0
dc.description.version Peer Reviewed
dc.identifier.journal BMJ Open Respiratory Research
dc.identifier.doi 10.1136/bmjresp-2018-000349
dc.relation.url https://syndication.highwire.org/content/doi/10.1136/bmjresp-2018-000349
dc.contributor.department Matvæla- og næringarfræðideild (HÍ)
dc.contributor.department Faculty of Food Science and Nutrition (UI)
dc.contributor.department Læknadeild (HÍ)
dc.contributor.department Faculty of Medicine (UI)
dc.contributor.school Heilbrigðisvísindasvið (HÍ)
dc.contributor.school School of Health Sciences (UI)


Files in this item

This item appears in the following Collection(s)

Show simple item record